ANPEP and rhabdomyosarcoma: In summary, this study demonstrated that APN deficiency could promote CD8+ T cell activation and their cytotoxicity to kill tumors via inhibiting the STAT3 signaling pathway, and proved that targeting APN had potential in the treatment of rhabdomyosarcoma.